{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:25:09Z","timestamp":1792081509320,"version":"4.4.0"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00149","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T10:35:15Z","timestamp":1581071715000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":200,"title":["Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis"],"prefix":"10.3389","volume":"11","author":[{"given":"Hsi-en","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J Clin Immunol"},{"key":"B3","unstructured":"ESID Registry - Working Definitions for Clinical Diagnosis of PID2014"},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1586\/1744666X.2014.875274","article-title":"New diagnostic criteria for CVID","volume":"10","author":"Ameratunga","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJM195406172502403","article-title":"Absence of serum gamma globulins in an adult","volume":"250","author":"Sanford","year":"1954","journal-title":"New Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jaci.2016.12.978","article-title":"Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies","volume":"140","author":"Fischer","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/jmedgenet-2015-103690","article-title":"Genes associated with common variable immunodeficiency: one diagnosis to rule them all?","volume":"53","author":"Bogaert","year":"2016","journal-title":"J Med Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","article-title":"Genetic diagnosis using whole exome sequencing in common variable immunodeficiency","volume":"7","author":"Maffucci","year":"2016","journal-title":"Front Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3389\/fimmu.2018.00636","article-title":"Evaluating the genetics of common variable immunodeficiency: monogenetic model and beyond","volume":"9","author":"de","year":"2018","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2141.2011.08880.x","article-title":"Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients","volume":"155","author":"Gobert","year":"2011","journal-title":"Br J Haematol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10875-012-9778-9","article-title":"Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients","volume":"33","author":"Boursiquot","year":"2013","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s10875-014-0079-3","article-title":"Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency","volume":"34","author":"Franxman","year":"2014","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jaci.2009.06.018","article-title":"Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes","volume":"124","author":"Agarwal","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","article-title":"Clinical picture and treatment of 2212 patients with common variable immunodeficiency","volume":"134","author":"Gathmann","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10875-007-9075-1","article-title":"Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency","volume":"27","author":"Quinti","year":"2007","journal-title":"J Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood."},{"key":"B22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/A:1011012023616","article-title":"Diagnostic findings in 95 finnish patients with common variable immunodeficiency","volume":"21","author":"Kainulainen","year":"2001","journal-title":"J Clin Immunol."},{"key":"B23","first-page":"31","article-title":"Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications","volume":"86","author":"Hermaszewski","year":"1993","journal-title":"Q J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.3389\/fimmu.2017.01740","article-title":"Common variable immunodeficiency non-infectious disease endotypes redefined using unbiased network clustering in large electronic datasets","volume":"8","author":"Farmer","year":"2017","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","article-title":"Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study","volume":"130","author":"Mellemkjaer","year":"2002","journal-title":"Clin Exp Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/ajg.2016.329","article-title":"A cross-sectional study of the prevalence of gastrointestinal symptoms and pathology in patients with common variable immunodeficiency","volume":"111","author":"J\u00f8rgensen","year":"2016","journal-title":"Am J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1513\/AnnalsATS.201512-826FR","article-title":"Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension","volume":"13","author":"Kimmig","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-kappaB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10875-016-0306-1","article-title":"NF-kappaB1 haploinsufficiency causing immunodeficiency and EBV-driven lymphoproliferation","volume":"36","author":"Boztug","year":"2016","journal-title":"J Clin Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0300-2977(01)00151-6","article-title":"Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance","volume":"59","author":"Nijenhuis","year":"2001","journal-title":"Neth J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.ejhg.5201634","article-title":"Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q","volume":"14","author":"Finck","year":"2006","journal-title":"Eur J Hum Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-kappaB1 Subunit p50 in Common Variable Immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am J Hum Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","article-title":"Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency","volume":"93","author":"Chen","year":"2013","journal-title":"Am J Hum Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","article-title":"Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype","volume":"130","author":"Kuehn","year":"2017","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","article-title":"Treg and CTLA-4: two intertwining pathways to immune tolerance","volume":"45","author":"Walker","year":"2013","journal-title":"J Autoimmun."},{"key":"B40","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MIB.0000000000000266","article-title":"Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype","volume":"21","author":"Serwas","year":"2015","journal-title":"Inflamm Bowel Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaci.2014.10.019","article-title":"Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA","volume":"135","author":"Charbonnier","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell."},{"key":"B48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1744-313X.2006.00627.x","article-title":"Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology","volume":"33","author":"Jou","year":"2006","journal-title":"Int J Immunogenet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science."},{"key":"B50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","article-title":"Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study","volume":"139","author":"Coulter","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","article-title":"Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K","volume":"211","author":"Lucas","year":"2014","journal-title":"J Exp Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood."},{"key":"B55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10875-015-0193-x","article-title":"Astute clinician report: a novel 10 bp frameshift deletion in Exon 2 of ICOS causes a combined immunodeficiency associated with an enteritis and hepatitis","volume":"35","author":"Robertson","year":"2015","journal-title":"J Clin Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","article-title":"Loss of B cells in patients with heterozygous mutations in IKAROS","volume":"374","author":"Kuehn","year":"2016","journal-title":"New Engl J Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jaci.2016.01.018","article-title":"Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder","volume":"138","author":"Keller","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10875-014-0121-5","article-title":"Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders","volume":"35","author":"Buchbinder","year":"2015","journal-title":"J Clin Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","article-title":"A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency","volume":"134","author":"Abolhassani","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1172\/JCI39748","article-title":"CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency","volume":"120","author":"van Zelm","year":"2010","journal-title":"J Clin Invest."},{"key":"B64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2011.09.027","article-title":"Genetic CD21 deficiency is associated with hypogammaglobulinemia","volume":"129","author":"Thiel","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"J Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jaci.2011.11.013","article-title":"CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia","volume":"129","author":"van Montfrans","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood."},{"key":"B72","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1172\/JCI69854","article-title":"CVID-associated TACI mutations affect autoreactive B cell selection and activation","volume":"123","author":"Romberg","year":"2013","journal-title":"J Clin Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"S\u00e1nchez-Ram\u00f3n","year":"2008","journal-title":"Clin Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood."},{"key":"B77","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/0394632015617064","article-title":"CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-gamma) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency","volume":"29","author":"Kutukculer","year":"2016","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.4049\/jimmunol.178.6.3932","article-title":"Unravelling the complexity of T cell abnormalities in common variable immunodeficiency","volume":"178","author":"Giovannetti","year":"2007","journal-title":"J Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2249.2001.01560.x","article-title":"Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas\/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS","volume":"125","author":"Di Renzo","year":"2001","journal-title":"Clin Exp Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/j.1365-2249.2006.03314.x","article-title":"Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivo","volume":"147","author":"Fevang","year":"2007","journal-title":"Clin Exp Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2015.01.002","article-title":"Clonal and constricted T cell repertoire in common variable immune deficiency","volume":"178","author":"Ramesh","year":"2017","journal-title":"Clin Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2249.1994.tb06512.x","article-title":"The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency","volume":"95","author":"Fischer","year":"1994","journal-title":"Clin Exp Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/jir.1995.15.269","article-title":"Immunologic effects of low-dose polyethylene glycol-conjugated recombinant human interleukin-2 in common variable immunodeficiency","volume":"15","author":"Cunningham-Rundles","year":"1995","journal-title":"J Interferon Cytok Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF00915297","article-title":"Interleukin-2 correction of defective in vitro T-cell mitogenesis in patients with common varied immunodeficiency","volume":"4","author":"Kruger","year":"1984","journal-title":"J Clin Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1182\/blood-2004-06-2423","article-title":"Abnormal interleukin-7 function in common variable immunodeficiency","volume":"105","author":"Holm","year":"2005","journal-title":"Blood."},{"key":"B88","doi-asserted-by":"publisher","first-page":"122728","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight."},{"key":"B89","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0091-6749(05)80207-6","article-title":"Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency","volume":"86","author":"Adelman","year":"1990","journal-title":"J Allergy Clin Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/clin.1994.1032","article-title":"Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes","volume":"70","author":"Aukrust","year":"1994","journal-title":"Clin Immunol Immunopathol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1006\/cbir.1994.1030","article-title":"On interleukins 4, 6 and 10 and their interrelationship with immunoglobulins G and M in common variable immunodeficiency","volume":"18","author":"Fritsch","year":"1994","journal-title":"Cell Biol Int."},{"key":"B92","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.159.12.6236","article-title":"TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease","volume":"159","author":"Mullighan","year":"1997","journal-title":"J Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e74893","DOI":"10.1371\/journal.pone.0074893","article-title":"Interferon signature in the blood in inflammatory common variable immune deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PLoS ONE."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2015.09.013","article-title":"Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency","volume":"137","author":"Cols","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/eji.201746961","article-title":"Reduced numbers of circulating group 2 innate lymphoid cells in patients with common variable immunodeficiency","volume":"47","author":"Geier","year":"2017","journal-title":"Eur J Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.20140039","article-title":"Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders","volume":"211","author":"Perreau","year":"2014","journal-title":"J Exp Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","article-title":"Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia","volume":"170","author":"Litzman","year":"2012","journal-title":"Clin Exp Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/mi.2016.18","article-title":"Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation","volume":"9","author":"J\u00f8rgensen","year":"2016","journal-title":"Mucosal Immunol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aar7201","article-title":"Translocation of a gut pathobiont drives autoimmunity in mice and humans","volume":"359","author":"Manfredo Vieira","year":"2018","journal-title":"Science."},{"key":"B100","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1073\/pnas.1814558116","article-title":"Loss of gut barrier integrity triggers activation of islet-reactive T cells and autoimmune diabetes","volume":"116","author":"Sorini","year":"2019","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00149\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T08:25:06Z","timestamp":1695716706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00149\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2020.00149"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00149","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"article-number":"149"}}